Effect of vitamin D supplementation for the recurrence of idiopathic benign paroxysmal positional vertigo

Effect of vitamin D supplementation for the recurrence of idiopathic benign paroxysmal positional vertigo: randomized, double-blind, placebo-controlled clinical trial.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0003320

Enrollment

160

Registered

2018-11-05

Start date

2018-11-06

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : 1. Voluntary written consent was given to patients who met the inclusion criteria who did not meet the exclusion criteria. After this, the subjects classified as a treatment group (Vitamin D) a

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) patients diagnosed with posterior semicircular canal benign paroxysmal positional vertigo (BPPV) or lateral canal BPPV. (2) Patients with a serum vitamin D (25-OH vitamin D) level below 20ng/ml (3) Patients who underwent appropriate repositioning maneuver for each subtype of BPPV and and were confirmed as complete resolution 1 week after initial diagnosis.

Exclusion criteria

Exclusion criteria: (1) Patients with a history of vestibular neuritis, labyrinthitis, Meniere's disease, ear surgery, inner ear disease, head trauma (2) Patients who have BPPV with involvement of anterior or multiple semicircular canal. (3) patients with a 25-OH vitamin D level above 20 ng/ml (4) Patients who had previously supplemented vitamin D.(injection or orally intake)

Design outcomes

Primary

Measure	Time frame
Recurrence rate of BPPV (benign paroximal positional vertigo)	—

Secondary

Measure	Time frame
serum 25-OH Vitamin D levels	—

Countries

Korea, Republic of

Contacts

Public ContactJa Won Koo

Myongji Hospital

crazy9482@naver.com+82-31-810-6360

Outcome results